2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$50.68+$0.04 (+0.09%)
Price as of Jul 13, 2026 7:58 PM EDT- $5.3BMarket Cap
- -10.26%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$50.68+$0.04 (+0.09%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $50.63 | ||
Change | -$2.72 (-5.10%) | ||
Open | $52.39 | ||
High | $52.96 | ||
Low | $50.18 | ||
Previous Close | $53.35 | ||
Volume | 1,965,020 | ||
30-Day Average Volume | 1,783,674 | ||
1-Week Change | -18.19% | ||
1-Month Change | 1.67% | ||
1-Year Change | -10.26% | ||
3-Year Change | -14.19% | ||
5-Year Change | -62.65% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $5.3B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$122.9M | ||
Free Cash Flow | -$109.4M | ||
EBIT | -$121.5M | ||
EBITDA | -$117.2M | ||
Net Working Capital | $2.3B | ||
EPS | -$1.28 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | 5,422 | ||
P/B | 3 | ||
P/E | -42 | ||
PEG | -6 | ||
Price/Free Cash Flow | -48 | ||
Price/Operating Cash Flow | -48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue